Effective immunotherapy for children with cancer was found more tolerable

The prestigious Journal „The Lancet“ publishes clinical trial results of pediatric oncologists

Neuroblastoma is associated with the highest death rate amongst children with cancer. Immunotherapy with a neuoblastoma specific antibody in combination with cytokines has improved the survival of this disease, and until now, the antibody treatment was only given in combination. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)